Portia Smallbone , Hematologist and Transplant Physician at MD Anderson Cancer Center, shared a post on X:
“Pleased to share our work recently published in American Journal of Hematology.
In patients with MF and splanchnic vein thrombosis, HCT is feasible and curative , although long term sequelae of portal HTN require ongoing management.”
Authors: Portia Smallbone et al.
